MDSCs of HCV-infected individuals, although poorly characterized compared to those derived from cancer patients, are able to inhibit T cell proliferation mainly by means of ARG1 (Cai et al., 2013) and ROS production (Tacke et al., 2012). The gene discussed is ARG1; the disease is cancer.